← European Medicine Shortage Tracker · all medicines

Daratumumab shortage — availability across Europe

Name: European Medicine Shortage Tracker dataset
Creator: MobiDoctor
License: https://creativecommons.org/licenses/by/4.0/

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED

Dr. Chrysoula I. Liakou MD, PhD

Internal Medicine Specialist
Cancer Immunology Researcher

Reviewed 30 July 2026 · next review due 30 January 2027

Daratumumab currently has availability issues reported in 1 European register: Italy.

Shortage ATC — · also listed as: DARATUMUMAB · data refreshed 8 September 2026

Key facts

As of 8 September 2026, Daratumumab has active availability issues in 1 of 9 tracked European registers.
Registers reporting issues: Italy.
Data source: 1 official medicines-agency register, refreshed daily.

As of 8 September 2026, 1 of the 9 tracked registers list current availability issues for Daratumumab, covering 1 affected product presentation. Where agencies state a cause, commercial decisions or discontinuation lead with 1 of the 1 stated-cause reports. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

Where	Status & products	Since	Expected end	Reason / alternatives	Source
🇮🇹 Italy	Shortage DARZALEX	2027-06-30	—	Cessata commercializzazione definitiva Alternatives: AIFA: an alternative treatment is available (ask your doctor).	register ↗

Full report history (1 register entry)

Every individual register entry for Daratumumab in the tracked sources, newest first — including resolved and discontinued reports.

Reg.	Product	Status	Reported	Expected end	Stated reason
🇮🇹 IT	DARZALEX	Shortage	2027-06-30	—	Cessata commercializzazione definitiva

Frequently asked

Is Daratumumab currently in shortage in Europe?

Yes. As of 8 September 2026, availability issues are reported in: Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

Are there alternatives to Daratumumab?

1 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Daratumumab availability data come from?

Directly from the official medicines-agency register that lists Daratumumab: AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Daratumumab — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/daratumumab/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Daratumumab availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/daratumumab/">Daratumumab shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>

Cite: “Daratumumab: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 8 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.